Entropy Technologies LP Sells 93,877 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Entropy Technologies LP cut its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 52.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 85,660 shares of the health services provider’s stock after selling 93,877 shares during the period. Entropy Technologies LP’s holdings in Teladoc Health were worth $779,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Blue Trust Inc. grew its position in shares of Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after buying an additional 1,854 shares during the period. Versant Capital Management Inc boosted its stake in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after acquiring an additional 2,441 shares during the last quarter. Westside Investment Management Inc. boosted its stake in Teladoc Health by 43.8% during the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after acquiring an additional 2,800 shares during the last quarter. Private Advisor Group LLC grew its holdings in Teladoc Health by 26.9% during the third quarter. Private Advisor Group LLC now owns 13,990 shares of the health services provider’s stock valued at $128,000 after purchasing an additional 2,962 shares during the period. Finally, KBC Group NV increased its stake in Teladoc Health by 72.3% in the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after purchasing an additional 3,714 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Insiders Place Their Bets

In other news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares of the company’s stock, valued at $34,477.70. This trade represents a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on TDOC shares. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Oppenheimer decreased their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Bank of America increased their price target on Teladoc Health from $10.50 to $11.50 and gave the stock a “neutral” rating in a report on Thursday, February 6th. TD Cowen cut their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Finally, The Goldman Sachs Group assumed coverage on Teladoc Health in a research note on Friday, November 15th. They set a “buy” rating and a $14.00 target price for the company. Fourteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $11.97.

Teladoc Health Stock Performance

TDOC opened at $12.99 on Wednesday. The business’s 50-day simple moving average is $10.13 and its 200 day simple moving average is $9.20. Teladoc Health, Inc. has a 52-week low of $6.76 and a 52-week high of $21.74. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm has a market capitalization of $2.24 billion, a PE ratio of -2.25 and a beta of 1.04.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.